JAIDEV CHAND SONI
Allopathic & Osteopathic Physicians|Radiology|Radiation Oncology DANVILLE, IL NPI 1811978752
Browse related groups: Allopathic & Osteopathic Physicians|Radiology|Radiation Oncology IL NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$2,436.64
- Category: General Payments
- Program years: PY2018–2023
- Record count: 167
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $172.10 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $172.10 | 8 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $24.63 | 1 |
| GENZYME CORPORATION | $23.84 | 1 |
| Merck Sharp & Dohme Corporation | $23.30 | 1 |
| EISAI INC. | $22.58 | 1 |
| Janssen Biotech, Inc. | $22.08 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $21.68 | 1 |
| Alexion Pharmaceuticals, Inc. | $18.71 | 1 |
| SEAGEN INC. | $15.28 | 1 |
By program year
Records — PY2023 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1000811470 | Bayer Healthcare Pharmaceuticals Inc. | $21.68 | 06/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1016991793 | Alexion Pharmaceuticals, Inc. | $18.71 | 06/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1023313359 | Eisai Inc. | $22.58 | 06/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1048410605 | Merck Sharp & Dohme LLC | $23.30 | 07/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1050344865 | GENZYME CORPORATION | $23.84 | 10/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 988684729 | Janssen Biotech, Inc. | $22.08 | 10/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 993325051 | Novartis Pharmaceuticals Corporation | $24.63 | 03/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 995739253 | Seagen Inc. | $15.28 | 06/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.